135 related articles for article (PubMed ID: 8000380)
1. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
Sagara K; Kawata M; Mizuta H; Shibata M
Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
[TBL] [Abstract][Full Text] [Related]
2. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
Hussein Z; Friedman M
Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.
Sagara K; Nagamatsu Y; Yamada I; Kawata M; Mizuta H; Ogawa K
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3303-6. PubMed ID: 1294333
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
[TBL] [Abstract][Full Text] [Related]
5. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
Miyazaki Y; Yakou S; Takayama K
J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
[TBL] [Abstract][Full Text] [Related]
7. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
Bayomi MA; Al-Suwayeh SA; El-Helw AR
Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
[TBL] [Abstract][Full Text] [Related]
8. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
Yomota C; Miyazaki T; Okada S
Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal physiology-regulated dogs: utilization of a bioavailability study of a new thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an antagonist of platelet-activating factor, and its preparations.
Sagara K; Yamada I; Kawazoe Y; Mizuta H; Shibata M
Biol Pharm Bull; 1994 Jan; 17(1):117-20. PubMed ID: 8148798
[TBL] [Abstract][Full Text] [Related]
11. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
13. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release oral delivery of theophylline by use of polyvinyl alcohol and polyvinyl alcohol-methyl acrylate polymers.
DiLuccio RC; Hussain MA; Coffin-Beach D; Torosian G; Shefter E; Hurwitz AR
J Pharm Sci; 1994 Jan; 83(1):104-6. PubMed ID: 8138896
[TBL] [Abstract][Full Text] [Related]
15. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
16. A multiple-dose study of sustained-release theophylline and aminophylline.
Meyer MC; Straughn AB; Lieberman P
Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
[TBL] [Abstract][Full Text] [Related]
17. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
Vashi VI; Meyer MC
J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
[TBL] [Abstract][Full Text] [Related]
18. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
Lagas M; Jonkman JH
Eur J Clin Pharmacol; 1983; 24(6):761-7. PubMed ID: 6884413
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
Gangadharan B; Ritschel WA; Hussain SA
Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
